Frank Schweizer
- Molecular Medicine top 0.05%
- Antibiotic Resistance in Bacteria 63
- Microbiology top 0.1%
- Antimicrobial Peptides and Activities 37
- Pharmacology top 0.2%
- Antibiotics Pharmacokinetics and Efficacy 31
- Clinical Biochemistry top 1%
-
- Carbohydrate Chemistry and Synthesis 43
-
- Glycosylation and Glycoproteins Research 35
- Chemical Synthesis and Analysis 28
-
- Antimicrobial Resistance in Staphylococcus 12
-
- Pneumonia and Respiratory Infections 11
- Co-authors
- George G. ZhanelJames A. KarlowskyHeather J. AdamPhilippe Lagacé‐WiensSheryl ZelenitskyRonald DomalaonTemilolu IdowuDaryl J. Hoban
- Journals
- Drugs (13 papers)Carbohydrate Research (13 papers)Journal of Medicinal Chemistry (8 papers)
- Partner nations
- CanadaJapanUnited States
In The Last Decade
Frank Schweizer
152 papers receiving 6.5k citations
Hit Papers
Peers
Comparison fields: 5 of 139
- Molecular Medicine 2.8k
- Applied Microbiology and Biotechnology 588
- Microbiology 1.5k
- Pharmacology 1.7k
- Clinical Biochemistry 395
Countries citing papers authored by Frank Schweizer
This map shows the geographic impact of Frank Schweizer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frank Schweizer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frank Schweizer more than expected).
Fields of papers citing papers by Frank Schweizer
This network shows the impact of papers produced by Frank Schweizer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frank Schweizer. The network helps show where Frank Schweizer may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Frank Schweizer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 3 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 3 | |
| 5 | 2023 | 4 | |
| 6 | 2023 | 1 | |
| 7 | 2023 | 5 | |
| 8 | 2023 | 3 | |
| 9 | 2022 | 15 | |
| 10 | 2021 | 18 | |
| 11 | 2020 | 37 | |
| 12 | 2019 | 17 | |
| 13 | Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and Multidrug-Resistant Gram-Negative Bacillibreakdown → | 2019 | 311 |
| 14 | 2018 | 219 | |
| 15 | 2013 | 194 | |
| 16 | 2013 | 118 | |
| 17 | 2012 | 27 | |
| 18 | 2012 | 25 | |
| 19 | 2009 | 16 | |
| 20 | 2003 | 4 |
About Frank Schweizer
Frank Schweizer is a scholar working on Molecular Medicine, Microbiology, Applied Microbiology and Biotechnology, Organic Chemistry and Pharmacology, having authored 153 papers that have together received 6.7k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (63 papers), Carbohydrate Chemistry and Synthesis (43 papers), Antimicrobial Peptides and Activities (37 papers), Glycosylation and Glycoproteins Research (35 papers), Antibiotics Pharmacokinetics and Efficacy (31 papers), Chemical Synthesis and Analysis (28 papers), Antimicrobial Resistance in Staphylococcus (12 papers) and Pneumonia and Respiratory Infections (11 papers). The work is most often cited by research in Molecular Medicine (2.8k citations), Applied Microbiology and Biotechnology (588 citations), Microbiology (1.5k citations), Pharmacology (1.7k citations) and Clinical Biochemistry (395 citations). Frank Schweizer has collaborated with scholars based in Canada, Japan and United States. Frequent co-authors include George G. Zhanel, James A. Karlowsky, Heather J. Adam, Philippe Lagacé‐Wiens, Sheryl Zelenitsky, Ronald Domalaon, Temilolu Idowu, Daryl J. Hoban, Alfred S. Gin and Brandon Findlay. Their work appears in journals such as Drugs, Carbohydrate Research, Journal of Medicinal Chemistry, Synlett and Molecules.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.